Management of dyslipidaemia in patients with coronary heart disease: Results from the ESC-EORP EUROASPIRE V survey in 27 countries


Kotseva K., Mirrakhimov E., Rydén L., Wood D., De Backer G., De Backer G., ...Daha Fazla

ATHEROSCLEROSIS, cilt.285, ss.135-146, 2019 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 285
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1016/j.atherosclerosis.2019.03.014
  • Dergi Adı: ATHEROSCLEROSIS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.135-146
  • Anahtar Kelimeler: LDL-Cholesterol, Coronary heart disease, EUROASPIRE, Secondary prevention, Dyslipidaemia, Lipid lowering therapy, CLINICAL-PRACTICE, MYOCARDIAL-INFARCTION, RISK-FACTORS, CARDIOVASCULAR OUTCOMES, PREVENTION GUIDELINES, EUROPEAN GUIDELINES, ESC/EAS GUIDELINES, LOWERING THERAPY, STATIN THERAPY, TASK-FORCE
  • Ankara Üniversitesi Adresli: Evet

Özet

Background and aims: One of the objectives of the ESC-EORP EUROASPIRE V survey is to determine how well European guidelines on the management of dyslipidaemias are implemented in coronary patients.